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DEPENDENCE OF THE ACTIVITY OF THE SYSTEM 
OF OXIDATIVE STRESS – ANTIOXIDANT PROTECTION ON 
INSULIN RESISTANCE IN PATIENTS WITH ESSENTIAL 
HYPERTENSION AND OBESITY. 
 
Relevance. The activation of free radical oxidative processes and the 
development of oxidative stress is one of the most important pathogenet-
ic mechanisms of cardiovascular diseases. Active forms of oxygen can 
change cellular infiltration of vessels and endothelial function, having an 
impact on a functional condition of the adhesive molecules intercellular 
adhesion molecule-1 and vascular cell adhesion molecule-1. Under con-
dition of insulin resistance (IR), the balance in the system of oxidative 
stress – antioxidant protection is disturbed, the result of which is insuffi-
cient resistance to the damaging effect of the LPO products. 
The aim of the study was to assess the dependence of the activity of 
the system of oxidative stress – antioxidant protection on insulin re-
sistance (IR) in patients with comorbidity of arterial hypertension and 
obesity. 
We examined 200 patients with hypertension and class I–II obesity. 
The patients were divided into two groups depending on IR: the first 
group included 80 patients without IR and the second group – 120 pa-
tients with IR. 
As the result of the study, it was established that the presence of IR 
affects the activity of the system of oxidative stress – antioxidant protec-
tion in comorbidity of hypertension and obesity. In the presence of IR, 
patients with hypertension and concomitant obesity have significantly 
higher levels of indicators of the system of oxidative stress (malondial-
dehyde (MDA) and diene conjugates (DC)) compared with patients 
without IR. In patients with comorbidity of hypertension and obesity, 
HOMA-IR directly correlated with the indicators of the oxidative stress 
system (MDA and DC) and inversely correlated with the indicator of 
total antioxidant protection. In hypertensive patients with obesity and no 
IR, an increase in HOMA-IR was associated with a decrease in total an-
tioxidant protection, and in patients with IR, an increase in HOMA-IR 
was associated with an increase in MDA and DC, as well as a decrease 
in total antioxidant protection. 
Keywords: insulin resistance, oxidative stress, antioxidant protec-
tion, hypertension, obesity. 
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ЗАЛЕЖНІСТЬ АКТИВНОСТІ СИСТЕМИ ОКСИДАТИВНОГО 
СТРЕСУ – АНТИОКСИДАНТНОГО ЗАХИСТУ ВІД 
НАЯВНОСТІ ІНСУЛІНОРЕЗИСТЕНТНОСТІ У ПАЦІЄНТІВ 
ІЗ ГІПЕРТОНІЧНОЮ ХВОРОБОЮ ТА ОЖИРІННЯМ.  
  
Мета роботи полягала в оцінюванні залежності активності сис-
теми оксидативного стресу – антиоксидантного захисту від наявно-
сті інсулінорезистентності (ІР) у пацієнтів із коморбідністю артері-
альної гіпертензії та ожиріння. 
Обстежено 200 пацієнтів із гіпертонічною хворобою (ГХ) та 
ожирінням І–ІІ ступенів. Пацієнти були поділені на дві групи зале-
жно від наявності у них ІР: до першої групи ввійшло 80 пацієнтів 
без ІР, до другої – 120 пацієнтів з ІР. 
У результаті проведеного дослідження встановлено, що наяв-
ність ІР впливає на активність системи оксидативного стресу – ан-
тиоксидантного захисту при коморбідності ГХ та ожиріння. За ная-
вності ІР пацієнти з ГХ і супутнім ожирінням мають достовірно 
вищі рівні показників системи оксидативного стресу (малонового 
діальдегіду (МДА) та дієнових кон’югатів (ДК)) порівняно з пацієн-
тами без ІР. У пацієнтів із коморбідністю ГХ та ожиріння HOMA-IR 
прямо корелює з показниками системи оксидативного стресу (МДА 
і ДК) і зворотно корелює з показником загального антиоксидантно-
го захисту. У гіпертензивних пацієнтів з ожирінням в умовах відсу-
тності ІР збільшення HOMA-IR асоціюється зі зниженням загально-
го антиоксидантного захисту, а в пацієнтів з ІР – зі збільшенням 
МДА і ДК, а також зниженням загального антиоксидантного захисту. 
Ключові слова: інсулінорезистентність, оксидативний стрес, 
антиоксидантний захист, гіпертонічна хвороба, ожиріння.  
 
Автор, відповідальний за листування: valentinapsareva27@gmail.com
 
Introduction 
The results of recent studies have shown that the 
activation of free radical oxidative processes and 
the development of oxidative stress is one of the 
most important pathogenetic mechanisms of 
cardiovascular diseases [1, 3, 5, 14]. Increased 
production of free radicals contributes to the 
development of endothelial dysfunction (ED) with a 
violation of the ratio of the influence of vasoactive 
substances and factors with a predominance of 
vasoconstrictor effects [2, 8, 12, 13]. The activity of 
free radical oxidative processes is estimated by the 
content of lipid peroxidation products (LPO) – 
diene conjugates (DC), malondialdehyde (MDA) 
and Schiff bases in blood serum. The effectiveness 
of antioxidant protection is evaluated by changes in 
the activity of superoxide dismutase, which binds 
reactive oxygen species with formation of hydrogen 
peroxide, glutathione peroxidase, which reduces 
lipid hydroperoxides, glutathione reductase, which 
restores glutathione by oxidation of NADPH, 
catalase, which destructs peroxide into lipid 
hydroperoxides, as well as by the overall 
antioxidant activity [1, 4, 5, 9].  
In general, LPO is a process in which oxidants, 
such as free radicals, attack lipids, primarily 
polyunsaturated fatty acids (PUFA), as a result of 
which hydrogen is cleaved from carbon, and 
released oxygen forms peroxide radicals and 
hydroperoxides. The main substrates for LPO are 
PUFA. In general, LPO consists of three stages: 
initiation, propagation and termination resulting in 
the formation of a wide range of oxidation 
products. In healthy individuals, the activity of the 
LPO system is opposed by the system of 
antioxidant protection, but in insulin-resistant (IR) 
states, the balance in the system of oxidative stress -
– antioxidant protection is disturbed, the result of 
which is insufficient resistance to the damaging 
effect of the LPO products [3, 4, 6, 9]. 
It has been established that IR and ED are 
closely associated conditions, since IR is 
considered an independent risk factor for 
dyslipidemia, systemic inflammation, and oxidative 
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stress, and ED is the link between IR and 
cardiovascular disease [7, 8, 11, 15-17]. 
At the same time, hypotheses regarding the 
primacy of the origin and relationships of IR and 
ED are quite contradictory, which leads to further 
study of these states.  
Thus, the aim of the study was to assess the 
dependence of the activity of the system of 
oxidative stress – antioxidant protection from the 
presence of IR in patients with comorbidity AH and 
obesity. 
Clinical characteristics of patients and 
research methods. 200 patients with essential 
hypertension (EH) and class І–ІІ obesity, who gave 
informed written consent to participate in the study 
and met the inclusion criteria, were examined. 
Patients were divided into two groups depending on 
IR presence: the first group included 80 patients 
without IR, the second – 120 patients with IR. 
Criteria for inclusion in the study: stage II, 
grade 2 EH; class I obesity (BMI – 30–34.9 kg/m
2
), 
class ІI obesity (BMI – 35–39.9 kg/m
2
), abdominal 
obesity (according to IDF criteria, 2005): waist 
circumference > 94 cm for men and > 80 cm for 
women; chronic heart failure (CHF) I – II 
functional classes (FC); preserved ejection fraction 
(EF) of the left ventricle (LV); normal glomerular 
filtration rate (GFR), normokreatininaemia, absence 
of proteinuria (only microalbuminuria is allowed); 
age of patients – 45-55 years. 
Criteria for exclusion from the study: the 
presence of comorbidities in patients with EH 
(acute coronary syndrome, post-infarction 
cardiosclerosis, severe rhythm and conduction 
disorders, rheumatic heart disease, systemic 
connective tissue diseases, oncological diseases, 
symptomatic arterial hypertension (AH), thyroid 
diseases, acute inflammatory processes); stage III, 
grade 3 EH; class III obesity; type 1 and type 2 
diabetes; III–IV FC CHF; moderately reduced and 
reduced LV EF; reduced GFR, the presence of 
proteinuria; age of patients less than 45 and more 
than 55 years; refusal of patients to participate in 
the study. 
IR was calculated using the НОМА model: 
HOMA-IR = blood glucose (mmol/l) × blood 
insulin (µAU/l) /22.5. 
HOMA-IR value 2.77 and greater was 
considered as IR presence. 
The concentration of insulin in the blood serum 
was determined using "Insulin ELISA" ("DRG 
Diagnostics", Germany) sets using solid-phase 
radioimmunological analysis. 
The condition of the prooxidant system was 
assessed by the levels of molecular products of 
LPO – DC and MDA, and the condition of the 
antioxidant protection system – by the overall 
antioxidant activity (during spectrophotometry). 
The results were processed by methods of 
variation statistics using the "STATISTICA" 
software. The data are presented as M ± σ, where M 
is the average value; σ is the standard deviation. 
During the significance analysis of the differences 
between the two groups in the severity of the index, 
expressed by a number, the Student's t-test was 
used. To estimate the degree of connectivity or 
synchronicity in the changes of indicators, the R – 
coefficient of linear correlation (Pearson product-
moment correlation) was calculated.  
Results and discussion 
The results of the study showed that the activity 
of the system of oxidative stress in hypertensive 
patients with obesity in the presence of IR was 
more pronounced than in patients without IR 
(Table 1). Thus, patients with IR had significantly 
(p = 0.000) higher levels of DC 
((33.444 ± 3.142) nmol/ml) than patients with EH 
without IR ((29.591 ± 2.094) nmol/ml). Similar 
differences were observed in MDA levels: 
(36.924 ± 2.860) nmol/ml with IR and 
(33.729 ± 3.447) nmol/ml without IR, which 
significantly (p = 0.000) distinguished the groups 
from each other. The established features are a 
confirmation of the important role of IR in the 
occurrence and progression of endothelial 
dysfunction. Thus, in the presence of IR endothelial 
dysfunction occurs long before the appearance of 
obvious disorders of carbohydrate metabolism. 
Considering the results and the presence of 
conflicting hypotheses of the relationship of IR and 
ED, IR can be considered, on the one hand, as a 
factor in the development of endothelial 
dysfunction, and on the other – as a consequence 
[1, 3, 5, 10].  
As for the indicator of activity of the antioxidant 
protection system (total antioxidant protection), 
during the study there was no significant difference 
in its levels in the presence and absence of IR 
(p = 0.149). It can be assumed that these features 
are associated with the fact that the system of 
oxidative stress is more sensitive to IR than the 
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Table 1 – Indicators of the system of oxidative stress – antioxidant protection in patients in the 
presence and absence of IR 
Indicators 
Рatients with EH and obesity, n = 200 
ІR absent, n = 80 ІR present,n = 120 р 
MDA, nmol/ml 33.729 ± 3.447 36.924 ± 2.860 0.000 
DC, nmol/ml 29.591 ± 2.094 33.444 ± 3.142 0.000 
Total antioxidant protection, mmol/l 1.068 ± 0.068 1.054 ± 0.064 0.149 
 
The next stage of the study was to assess the 
degree of coherence and synchronicity in the 
changes of indicators by conducting a correlation 
analysis with the calculation of the coefficient of 
linear correlation (r) (Pearson product-moment 
correlation). 
As a result of the correlation analysis in patients 
with comorbidity EH and obesity, the relationship 
of indicators of the system of oxidative stress – 
antioxidant protection and HOMA-IR was 
established (Table 2–4). 
Table 2 – Correlation analysis of indicators of the system of oxidative stress – antioxidant protection 
with HOMA-IR in the General group of patients with EH and obesity 
Indicators 
Рatients with EH and obesity, n = 200 
r р 
MDA 0.457 0.000 
DC 0.608 0.000 
Total antioxidant protection –0.250 0.000 
 
In particular, it was found that in the General 
group of patients with EH and concomitant obesity 
(without division into groups based on the absence 
of IR) indicators of oxidative stress system (MDA 
and DC) had direct correlations with HOMA-IR 
(r = 0.457, p = 0.000 and r = 0.608, p = 0.000, 
respectively), the indicator of total antioxidant 
protection had inverse correlations with HOMA-IR 
(r = –0.250, p = 0.000) (Table 2). 
Table 3 – Correlation analysis of indicators of the system of oxidative stress – antioxidant protection 
with HOMA-IR in the group of patients without IR 
Indicators 
Рatients with EH and obesity, n = 80 
r р 
MDA 0.042 0.710 
DC 0.006 0.961 
Total antioxidant protection –0.409 0.000 
 
The division of patients into groups according to 
IR showed that the presence of IR affects the 
association of HOMA-IR with indicators of the 
system of oxidative stress – antioxidant protection. 
In patients without IR, HOMA-IR was associated 
with a decrease in overall antioxidant protection, 
which was confirmed by the presence of an inverse 
correlation (r = 0.409, p = 0.000) (Table 3). 
Table 4 – Correlation analysis of indicators of the system of oxidative stress – antioxidant protection 
with HOMA-IR in the group of patients with IR 
Indicators 
Рatients with EH and obesity, n = 120 
r р 
MDA 0.219 0.016 
DC 0.353 0.000 
Total antioxidant protection –0.314 0.000 
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It should be noted that in the presence of IR 
increase of HOMA-IR was also accompanied by a 
decrease in the activity of the total antioxidant 
protection, as evidenced by the inverse correlation 
with HOMA-IR (r = –0.314, p = 0.000) (Table 4). 
However, in patients with comorbidity EH and 
obesity in the presence of IR, the increase of 
HOMA-IR was associated with an increase in 
oxidative stress system indicators (MDA and DC), 
which was confirmed by the presence of their direct 
correlations with HOMA-IR (r = 0.219, p = 0.016 
and r = 0.353, p = 0.000, respectively). 
 
Conclusions  
The presence of IR affects the activity of the 
system of oxidative stress – antioxidant protection 
in comorbidity EH and obesity.  
In the presence of IR, patients with EH and 
concomitant obesity have significantly higher levels 
of the oxidative stress system indicators (MDA and 
DC) compared to patients without IR. 
In patients with comorbidity EH and obesity 
HOMA-IR directly correlates with oxidative stress 
system indicators (MDA and DC) and inversely 
correlates with the indicator of total antioxidant 
protection. 
In hypertensive patients with obesity in the 
absence of IR, increased HOMA-IR is associated 
with reduced total antioxidant protection and in 
patients with IR – with an increase of MDA and 
DC, as well as a decline in overall antioxidant 
protection.
Prospects for further research 
Prospects for further research are to assess the 
effect of IR on haemodynamic and metabolic 
parameters of patients with EH and concomitant 
obesity. 
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